A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

Ryan Seacrest Foundation selects Cohen Children’s Medical Center as location for its newest Seacrest Studio

What To Know

  • The studio will be a great addition to our Child Life programs, all of which are designed to give our young patients the opportunity to play and relieve the stress of being in the hospital setting.
  •  We've been fortunate to continue to grow and do the work we love, putting smiles on the faces of children and their families across the country and I can't wait to cut the ribbon on this one in 2022.

Cohen Children’s Medical Center was selected by the Ryan Seacrest Foundation (RSF) as the recipient of its newest Seacrest Studio, a state-of-the-art studio for pediatric patients to explore the creative realms of radio, television and new media. Cohen Children’s Medical Center will be home to the foundation’s 12th studio of this kind nationwide – and the only one in New York.

The studio, opening in 2022, will be located prominently in the atrium of Cohen Children’s Medical Center. Seacrest Studios are charitable endeavors of the Ryan Seacrest Foundation, founded by radio and television host and producer Ryan Seacrest along with his family. RSF hopes to contribute positively to the healing process for children and their families during their stay, as well as uplift spirits of the clinical and administrative staff at Cohen Children’s.

“The last two years have been unlike any other and I’m incredibly proud of the Ryan Seacrest Foundation for continuing to provide a creative outlet for patients and families during this difficult time,” said Ryan Seacrest. “I’m thrilled to announce our next location at New York’s Cohen Children’s Medical Center, which is near to my heart, in the city that I now call home. We’ve been fortunate to continue to grow and do the work we love, putting smiles on the faces of children and their families across the country and I can’t wait to cut the ribbon on this one in 2022.”

Seacrest made the announcement this morning on “LIVE with Kelly and Ryan,” the syndicated morning television talk show he co-hosts with Kelly Ripa.

Watch the announcement: https://www.northwell.edu/news/in-the-news/ryan-seacrest-studio-comes-to-cohen-children-039-s-medical-center

Seacrest Studios will be used to provide a variety of programming to patients, whether they are physically in the studio or watching through a closed-circuit network from their in-room television screen. Patients will have the opportunity to host their own radio and television shows, watch live musical performances, play games and even interview celebrity guests that visit. The studio will be encased in glass, allowing patients and visitors to view the daily programming happening inside.

“One of the primary goals for us at Cohen Children’s Medical Center is to continually improve and enhance the in-hospital experience, both for our patients and their families,” said Charles Schleien, MD, senior vice president and executive director of Cohen Children’s. “We are so grateful to the Ryan Seacrest Foundation for helping us provide an exciting new creative outlet at our hospital. The studio will be a great addition to our Child Life programs, all of which are designed to give our young patients the opportunity to play and relieve the stress of being in the hospital setting.”

Cohen Children’s Medical Center is the top-rated children’s hospital in New York State and has earned top national rankings for exceptional care in nine pediatric specialties, according to US News & World Report’s 2021-2022 Best Children’s Hospitals. As the largest provider of pediatric health care services in the state, Cohen Children’s has been ranked among the nation’s top children’s hospitals by US News for 15 consecutive years.

RSF has opened 11 other Seacrest Studios across the country: Atlanta, Boston, Charlotte, Cincinnati, Dallas, Denver, Nashville, Orange County, Orlando, Philadelphia and Washington, D.C.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

X-Therma notes this DMF covers the Chemistry, Manufacturing and Controls (CMC) for this key chemistry innovation, which enables non-toxic cryopreservation for life-saving regenerative medicines.
Simpson Interventions is committed to collaborating closely with the FDA and other stakeholders to advance the development and regulatory review of the Acolyte Image Guided Crossing and Re-Entry Catheter System. The company looks forward to bringing this revolutionary technology to clinicians, and patients in need.
"The U.S. approval of TriClip is a significant advancement for people suffering from tricuspid regurgitation, a heart condition that negatively impacts their quality of life and puts them at grave risk of serious health issues," said Paul Sorajja, M.D., the Roger L. and Lynn C. Headrick Family Chair of the Valve Science Center for the Minneapolis Heart Institute Foundation and director of the Center for Valve and Structural Heart Disease for the Minneapolis Heart Institute at Abbott Northwestern Hospital and co-principal investigator of the TRILUMINATE™ Pivotal trial. "With TriClip, physicians can offer patients a therapy option backed by excellent safety and effectiveness to help restore tricuspid native valve performance without subjecting them to high-risk open-heart surgery that may not be feasible for individuals with TR who are generally older and sicker."
This make it one of the only wearable OTC anti-migraine device that is available without a prescription in the U.S.
NanoDrop has received clearance in the United States as the inaugural blood-lancing device available for over-the-counter use on the upper arm. This development is poised to revolutionize the consumer testing market and decentralized clinical trials within the realm of at-home healthcare.

By using this website you agree to accept Medical Device News Magazine Privacy Policy